Detalhe da pesquisa
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682738
2.
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report.
Anticancer Drugs
; 33(10): 1171-1174, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206104
3.
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents.
Anticancer Drugs
; 33(1): e43-e51, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387593
4.
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Oncol
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704358
5.
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Cancer Cell
; 42(4): 646-661.e9, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428412
6.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Cancers (Basel)
; 15(8)2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190322
7.
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol
; 18(4): 559-570, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369815
8.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530662
9.
Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis.
Expert Opin Drug Metab Toxicol
; 18(3): 235-240, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485878
10.
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis.
Expert Opin Drug Metab Toxicol
; 17(10): 1237-1243, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407702
11.
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Ther Adv Med Oncol
; 13: 17588359211019642, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046089
12.
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.
Science
; 374(6564): 216-224, 2021 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618582
13.
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060148
14.
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Eur J Cancer
; 135: 159-169, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580131
15.
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
Cancers (Basel)
; 12(1)2019 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905816
16.
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival.
Breast
; 29: 24-30, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27394675
17.
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
J Exp Clin Cancer Res
; 35: 50, 2016 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000271